T 1214/18 of 04.07.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T121418.20220704
- Date of decision
- 4 July 2022
- Case number
- T 1214/18
- Petition for review of
- -
- Application number
- 07836007.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
- Applicant name
- Gilead Sciences, Inc.
- Opponent name
- Teva Pharmaceutical Industries Ltd
Trösch, Dominique
Georg Kalhammer/Stephan Teipel - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56
- Keywords
- Amendments
Inventive step - Catchword
- -
- Cited cases
- T 0948/02
- Citing cases
- T 1442/19
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form with the following claims, and a description to be adapted thereto:
Claims 1 and 2 of the main request, filed as auxiliary request 1 with the reply to the statements of grounds of appeal